e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Airway disease-associated exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting treatment outcomes following an exacerbation of airways disease
A. Halner (Oxford, United Kingdom), S. Beer (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), R. Russell (Oxford, United Kingdom)
Source:
International Congress 2019 – Airway disease-associated exacerbations
Session:
Airway disease-associated exacerbations
Session type:
Thematic Poster
Number:
4291
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Halner (Oxford, United Kingdom), S. Beer (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom), R. Russell (Oxford, United Kingdom). Predicting treatment outcomes following an exacerbation of airways disease. 4291
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk.
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes
Source: Eur Respir J 2003; 21: 30S-35S
Year: 2003
Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD
Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017
Year: 2017
Predictors of asthma exacerbation after treatment cessation
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003
Measuring adherence to therapy in airways disease
Source: Breathe, 17 (2) 210037; 10.1183/20734735.0037-2021
Year: 2021
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Identifying tools to investigate outcomes following an exacerbation of COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Does the severity of chronic obstructive pulmonary disease reflect on the outcomes of pulmonary rehabilitation?
Source: Annual Congress 2007 - Assessment and outcomes in patients with chronic airway obstruction
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept